1. Home
  2. AZTR vs SLXN Comparison

AZTR vs SLXN Comparison

Compare AZTR & SLXN Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AZTR
  • SLXN
  • Stock Information
  • Founded
  • AZTR 2014
  • SLXN 2008
  • Country
  • AZTR United States
  • SLXN Israel
  • Employees
  • AZTR N/A
  • SLXN N/A
  • Industry
  • AZTR Biotechnology: Pharmaceutical Preparations
  • SLXN
  • Sector
  • AZTR Health Care
  • SLXN
  • Exchange
  • AZTR Nasdaq
  • SLXN NYSE
  • Market Cap
  • AZTR 5.0M
  • SLXN 4.3M
  • IPO Year
  • AZTR 2023
  • SLXN N/A
  • Fundamental
  • Price
  • AZTR $0.37
  • SLXN $0.84
  • Analyst Decision
  • AZTR
  • SLXN Strong Buy
  • Analyst Count
  • AZTR 0
  • SLXN 1
  • Target Price
  • AZTR N/A
  • SLXN $9.00
  • AVG Volume (30 Days)
  • AZTR 17.8M
  • SLXN 31.1M
  • Earning Date
  • AZTR 03-14-2025
  • SLXN 03-04-2025
  • Dividend Yield
  • AZTR N/A
  • SLXN N/A
  • EPS Growth
  • AZTR N/A
  • SLXN N/A
  • EPS
  • AZTR N/A
  • SLXN N/A
  • Revenue
  • AZTR $97,500.00
  • SLXN N/A
  • Revenue This Year
  • AZTR N/A
  • SLXN N/A
  • Revenue Next Year
  • AZTR N/A
  • SLXN N/A
  • P/E Ratio
  • AZTR N/A
  • SLXN N/A
  • Revenue Growth
  • AZTR N/A
  • SLXN N/A
  • 52 Week Low
  • AZTR $0.23
  • SLXN $0.21
  • 52 Week High
  • AZTR $12.00
  • SLXN $13.56
  • Technical
  • Relative Strength Index (RSI)
  • AZTR 51.23
  • SLXN N/A
  • Support Level
  • AZTR $0.35
  • SLXN N/A
  • Resistance Level
  • AZTR $0.45
  • SLXN N/A
  • Average True Range (ATR)
  • AZTR 0.08
  • SLXN 0.00
  • MACD
  • AZTR 0.01
  • SLXN 0.00
  • Stochastic Oscillator
  • AZTR 36.26
  • SLXN 0.00

About AZTR Azitra Inc

Azitra Inc is an early-stage clinical biopharmaceutical company focused on developing therapies for precision dermatology using engineered proteins and live biotherapeutic products that can be applied topically to treat diseases of the skin. The company has built a proprietary platform that includes a microbial library comprised of bacterial strains that can be screened for therapeutic characteristics. The platform is augmented by artificial intelligence and machine learning technology that analyzes, predicts and helps screen the library of strains for drug-like molecules. The platform also utilizes a licensed genetic engineering technology, which can enable the transformation of previously genetically intractable strains.

About SLXN BIOMOTION SCIENCES

Silexion Therapeutics Corp is a developmental-stage company dedicated to the development of treatments for pancreatic cancer. The company is focused on enhancing its first-generation product (LODERTM ) to develop a newly formulated product to improve the clinical efficacy against pancreatic cancer.

Share on Social Networks: